Bacitracin/lidocaine/neomycin/polymyxin b topical Interactions
There are 100 drugs known to interact with bacitracin/lidocaine/neomycin/polymyxin b topical, along with 7 disease interactions. Of the total drug interactions, 2 are major, 91 are moderate, and 7 are minor.
Medications known to interact with bacitracin/lidocaine/neomycin/polymyxin b topical
Note: Showing generic names only.
A
- acebutolol
- acetaminophen
- amikacin
- amikacin liposome
- aminosalicylic acid
- amiodarone
- amyl nitrite
- atenolol
- atovaquone
- atracurium
B
C
- carteolol
- carvedilol
- celecoxib
- chloroprocaine
- chloroquine
- cimetidine
- ciprofloxacin
- cisatracurium
- cyclophosphamide
D
E
F
G
H
I
K
L
M
N
- nadolol
- nebivolol
- neomycin
- netilmicin
- nitric oxide
- nitrofurantoin
- nitroglycerin
- nitroprusside
- nitrous oxide
P
- pancuronium
- penbutolol
- phenazopyridine
- phenobarbital
- phenytoin
- pindolol
- pipecuronium
- plazomicin
- prilocaine
- primaquine
- procaine
- procaine penicillin
- propranolol
Q
R
S
- silver nitrate topical
- silver sulfadiazine topical
- sodium nitrite
- sotalol
- streptomycin
- succinylcholine
- sulfadiazine
- sulfamethizole
- sulfamethoxazole
- sulfasalazine
- sulfisoxazole
T
V
Bacitracin/lidocaine/neomycin/polymyxin b topical disease interactions
There are 7 disease interactions with bacitracin / lidocaine / neomycin / polymyxin b topical which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- perforated tympanic membrane
- burns
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.